Literature DB >> 2503020

Deep inspiration increases the absorption of inhaled sodium cromoglycate.

R Richards1, C Fowler, S F Simpson, A G Renwick, S T Holgate.   

Abstract

The plasma concentrations of sodium cromoglycate were measured for 4 h following a single dose of 20 mg given by inhalation to six normal volunteers. A series of forced expiratory manoeuvres was performed 2 h after the dose, which resulted in a rapid and marked increase in the plasma concentrations of the drug. A similar increase was found in three volunteers who undertook a single deep inspiration at 4 h. These data indicate that the absorption of cromoglycate from the airways can be affected by manoeuvres used to assess lung function.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2503020      PMCID: PMC1379815          DOI: 10.1111/j.1365-2125.1989.tb03450.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  The pharmacokinetics of nedocromil sodium, a new drug for the treatment of reversible obstructive airways disease, in human volunteers and patients with reversible obstructive airways disease.

Authors:  M G Neale; K Brown; R A Foulds; S Lal; D A Morris; D Thomas
Journal:  Br J Clin Pharmacol       Date:  1987-10       Impact factor: 4.335

Review 2.  Pulmonary clearance of 99mTc-DTPA: a noninvasive assessment of epithelial integrity.

Authors:  H O'Brodovich; G Coates
Journal:  Lung       Date:  1987       Impact factor: 2.584

3.  The pharmacokinetics of sodium cromoglycate in man after intravenous and inhalation administration.

Authors:  M G Neale; K Brown; R W Hodder; R M Auty
Journal:  Br J Clin Pharmacol       Date:  1986-10       Impact factor: 4.335

4.  Lung inflation, lung solute permeability, and alveolar edema.

Authors:  E A Egan
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1982-07

5.  Response of alveolar epithelial solute permeability to changes in lung inflation.

Authors:  E A Egan
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1980-12

6.  Absorption and disposition kinetics of cromolyn sodium and the influence of inhalation technique.

Authors:  R Richards; C R Dickson; A G Renwick; R A Lewis; S T Holgate
Journal:  J Pharmacol Exp Ther       Date:  1987-06       Impact factor: 4.030

7.  Site of deposition and factors affecting clearance of aerosolized solute from canine lungs.

Authors:  N W Rizk; J M Luce; J M Hoeffel; D C Price; J F Murray
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1984-03

8.  The pharmacokinetic assessment of sodium cromoglycate.

Authors:  R W Fuller; J G Collier
Journal:  J Pharm Pharmacol       Date:  1983-05       Impact factor: 3.765

9.  Inhalation rate of sodium cromoglycate determines plasma pharmacokinetics and protection against AMP-induced bronchoconstriction in asthma.

Authors:  R Richards; S F Simpson; A G Renwick; S T Holgate
Journal:  Eur Respir J       Date:  1988-12       Impact factor: 16.671

10.  Radioimmunoassay of sodium cromoglycate in human plasma.

Authors:  K Brown; J J Gardner; W J Lockley; J R Preston; D J Wilkinson
Journal:  Ann Clin Biochem       Date:  1983-01       Impact factor: 2.057

View more
  2 in total

Review 1.  The effect of respiratory disorders on clinical pharmacokinetic variables.

Authors:  A M Taburet; C Tollier; C Richard
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

2.  The effect of respiratory manoeuvres and pharmacological agents on the pharmacokinetics of nedocromil sodium after inhalation.

Authors:  Q A Summers; S Singh; R G Honeywell; A G Renwick; S T Holgate
Journal:  Br J Clin Pharmacol       Date:  1992-04       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.